Table 3.
Logistic regression analysis predicting switching TNF inhibitors vs. discontinuing TNF inhibitors
| Regression coefficient | Standard error | Chi-square | Odds ratio (95% CI) | p value | |
|---|---|---|---|---|---|
| Intercept | − 1.2949 | 0.1837 | 49.6609 | < 0.0001 | |
| Gender (female) | 0.3455 | 0.1390 | 6.1792 | 1.413 (1.076–1.855) | 0.0129 |
| Medicaid | − 0.8016 | 0.3670 | 4.7699 | 0.449 (0.218–0.921) | 0.0290 |
| Medicare | − 1.2866 | 0.4241 | 9.2061 | 0.276 (0.120–0.634) | 0.0024 |
| Use of cDMARD | 0.3034 | 0.1505 | 4.0631 | 1.354 (1.008–1.819) | 0.0438 |
| Use of non-opioid analgesics | 0.6615 | 0.1785 | 13.7264 | 1.938 (1.366–2.749) | 0.0002 |